GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hubei Hongyuan Pharmaceutical Technology Co Ltd (SZSE:301246) » Definitions » Inventory-to-Revenue

Hubei Hongyuan Pharmaceutical Technology Co (SZSE:301246) Inventory-to-Revenue : 0.49 (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Hubei Hongyuan Pharmaceutical Technology Co Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Hubei Hongyuan Pharmaceutical Technology Co's Average Total Inventories for the quarter that ended in Mar. 2024 was ¥208 Mil. Hubei Hongyuan Pharmaceutical Technology Co's Revenue for the three months ended in Mar. 2024 was ¥426 Mil. Hubei Hongyuan Pharmaceutical Technology Co's Inventory-to-Revenue for the quarter that ended in Mar. 2024 was 0.49.

Hubei Hongyuan Pharmaceutical Technology Co's Inventory-to-Revenue for the quarter that ended in Mar. 2024 increased from Dec. 2023 (0.42) to Dec. 2023 (0.49)

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Hubei Hongyuan Pharmaceutical Technology Co's Days Inventory for the three months ended in Mar. 2024 was 52.94.

Inventory Turnover measures how fast the company turns over its inventory within a year. Hubei Hongyuan Pharmaceutical Technology Co's Inventory Turnover for the quarter that ended in Mar. 2024 was 1.72.


Hubei Hongyuan Pharmaceutical Technology Co Inventory-to-Revenue Historical Data

The historical data trend for Hubei Hongyuan Pharmaceutical Technology Co's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hubei Hongyuan Pharmaceutical Technology Co Inventory-to-Revenue Chart

Hubei Hongyuan Pharmaceutical Technology Co Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventory-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.13 0.24 0.23 0.18 0.13

Hubei Hongyuan Pharmaceutical Technology Co Quarterly Data
Jun15 Dec15 Jun16 Dec18 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Inventory-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.63 0.58 0.46 0.42 0.49

Competitive Comparison of Hubei Hongyuan Pharmaceutical Technology Co's Inventory-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Hubei Hongyuan Pharmaceutical Technology Co's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hubei Hongyuan Pharmaceutical Technology Co's Inventory-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hubei Hongyuan Pharmaceutical Technology Co's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Hubei Hongyuan Pharmaceutical Technology Co's Inventory-to-Revenue falls into.



Hubei Hongyuan Pharmaceutical Technology Co Inventory-to-Revenue Calculation

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Hubei Hongyuan Pharmaceutical Technology Co's Inventory-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Inventory-to-Revenue (A: Dec. 2023 )
=Average Total Inventories / Revenue
=( (Total Inventories (A: Dec. 2022 ) + Total Inventories (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )
=( (352.947 + 191.506) / 2 ) / 2054.882
=272.2265 / 2054.882
=0.13

Hubei Hongyuan Pharmaceutical Technology Co's Inventory-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Inventory-to-Revenue (Q: Mar. 2024 )
=Average Total Inventories / Revenue
=( (Total Inventories (Q: Dec. 2023 ) + Total Inventories (Q: Mar. 2024 )) / count ) / Revenue (Q: Mar. 2024 )
=( (191.506 + 225.12) / 2 ) / 426.064
=208.313 / 426.064
=0.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hubei Hongyuan Pharmaceutical Technology Co  (SZSE:301246) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Hubei Hongyuan Pharmaceutical Technology Co's Days Inventory for the three months ended in Mar. 2024 is calculated as:

Days Inventory=Average Total Inventories (Q: Mar. 2024 )/Cost of Goods Sold (Q: Mar. 2024 )*Days in Period
=208.313/359.025*365 / 4
=52.94

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Hubei Hongyuan Pharmaceutical Technology Co's Inventory Turnover for the quarter that ended in Mar. 2024 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Mar. 2024 ) / Average Total Inventories (Q: Mar. 2024 )
=359.025 / 208.313
=1.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hubei Hongyuan Pharmaceutical Technology Co Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Hubei Hongyuan Pharmaceutical Technology Co's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Hubei Hongyuan Pharmaceutical Technology Co (SZSE:301246) Business Description

Traded in Other Exchanges
N/A
Address
No. 8, Hongyuan Road, Economic Development Zone, Luotian County, Hubei Province, Fengshan Town, CHN, 438600
Hubei Hongyuan Pharmaceutical Technology Co Ltd is engaged in the research and development, production and sales of organic chemical raw materials, pharmaceutical intermediates, raw materials and pharmaceutical preparations.

Hubei Hongyuan Pharmaceutical Technology Co (SZSE:301246) Headlines

No Headlines